Genmab A/S

Genmab A/S Supply Chain

Supply Chain of Genmab A/S (GMAB.CO) as of Oct 11, 2026.

Supply Chain

-

Last updated:

Supply chains in stock corporations are essential components of business infrastructure and play a crucial role in value creation and competitiveness. These supply chains encompass all steps from raw material procurement and production to the delivery of finished products to the end customer.

Genmab A/S Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
17 companies
#Nameβ 1YTrend
1
BioNTech ADR
Supplier·Customer·Biotechnology·DE
0.35
-0.55
0.31
0.53
0.78
0.75
—
2
BlackRock
Supplier·Customer·Capital Markets·US
-0.26
0.77
0.43
0.44
0.73
0.64
0.49
3
Immatics
Supplier·Customer·Biotechnology·DE
0.37
0.89
0.85
0.54
0.78
0.49
—
4
Roche Holding
Supplier·Customer·Pharmaceuticals·CH
-0.73
0.86
0.51
0.47
-0.10
0.41
-0.07
5
Novo Nordisk B
Supplier·Customer·DK
-0.26
0.67
0.54
0.48
-0.29
0.38
—
6
Johnson & Johnson
Supplier·Customer·Pharmaceuticals·US
-0.63
-0.19
0.17
-0.12
-0.21
0.31
-0.10
#Nameβ 1YTrend
1
CureVac
Supplier·Customer·Biotechnology·DE
0.82
0.12
0.23
0.53
0.78
—
1.48
2
Bolt Biotherapeutics
Supplier·Customer·Biotechnology·US
0.29
0
0.12
0.29
0.81
—
—
3
Amgen
Supplier·Customer·Biotechnology·US
0.52
-0.80
0.47
0.04
-0.31
-0.40
-0.22
4
H Lundbeck
Supplier·Customer·Pharmaceuticals·DK
0.78
0.16
0.10
0.31
0.72
-0.20
—
5
Bristol-Myers Squibb
Supplier·Customer·Pharmaceuticals·US
0.13
-0.40
0.34
-0.14
-0.40
-0.04
-0.25
6
ADC Therapeutics
Supplier·Customer·Biotechnology·CH
-0.07
0.95
0.53
0.47
0.84
-0.03
—
7
AbbVie
Supplier·Customer·Biotechnology·US
-0.54
0.71
0.63
-0.09
-0.69
0.03
-0.44
8
Open Orphan
Supplier·Life Sciences Tools & Services·GB
-0.90
0.69
-0.18
-0.02
0.44
0.08
—
9
Novartis
Supplier·Customer·Pharmaceuticals·CH
-0.68
0.55
-0.26
-0.43
0
0.10
0.00
10
Ligand Pharmaceuticals
Supplier·Customer·Biotechnology·US
-0.20
0.83
0.48
0.54
0.46
0.23
—
11
Seagen
Supplier·Customer·Biotechnology·US
0.43
-0.18
0.38
0.65
0.78
0.25
—
Access this data via the Eulerpool API
Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

All Key Metrics — Genmab A/S